Syros Pharmaceuticals, Inc. - common stock (SYRS): Price and Financial Metrics

SYRS POWR Grades

• Growth is the dimension where SYRS ranks best; there it ranks ahead of 83.66% of US stocks.
• SYRS's strongest trending metric is Growth; it's been moving up over the last 179 days.
• SYRS ranks lowest in Momentum; there it ranks in the 16th percentile.

SYRS Stock Summary

• Of note is the ratio of SYROS PHARMACEUTICALS INC's sales and general administrative expense to its total operating expenses; merely 7.49% of US stocks have a lower such ratio.
• As for revenue growth, note that SYRS's revenue has grown -64.65% over the past 12 months; that beats the revenue growth of merely 3.63% of US companies in our set.
• SYROS PHARMACEUTICALS INC's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -147.86%, greater than the shareholder yield of only 3.74% of stocks in our set.
• If you're looking for stocks that are quantitatively similar to SYROS PHARMACEUTICALS INC, a group of peers worth examining would be IKNA, SPRB, IPSC, ATHX, and CTMX.
• SYRS's SEC filings can be seen here. And to visit SYROS PHARMACEUTICALS INC's official web site, go to www.syros.com.

SYRS Valuation Summary

• SYRS's price/sales ratio is 9.1; this is 127.5% higher than that of the median Healthcare stock.
• SYRS's price/earnings ratio has moved up 9.2 over the prior 88 months.

Below are key valuation metrics over time for SYRS.

SYRS Growth Metrics

The 5 year net cashflow from operations growth rate now stands at 7.16%.
• The year over year cash and equivalents growth rate now stands at -67.74%.
• The 3 year net cashflow from operations growth rate now stands at -84.69%.

SYRS's revenue has moved up $3,920,000 over the prior 15 months.

The table below shows SYRS's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	23.436	-114.951	-113.693
2022-06-30	25.242	-107.291	-109.467
2022-03-31	24.128	-107.567	-97.476
2021-12-31	23.488	-99.54	-86.558
2021-09-30	21.385	-106.495	-92.875
2021-06-30	19.516	-93.623	-86.334

SYRS's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• SYRS has a Quality Grade of C, ranking ahead of 31.76% of graded US stocks.
• SYRS's asset turnover comes in at 0.093 -- ranking 271st of 682 Pharmaceutical Products stocks.
• ONVO, OPK, and ICPT are the stocks whose asset turnover ratios are most correlated with SYRS.

The table below shows SYRS's key quality metrics over time.